Journey Medical Corp
DERM
Get informed when a big investor buys or sells
+ FollowMarket Cap$171.19M
Close$
$-5.57
183.1% downside
Current Fair Value
183.1% downsideOvervalued by 183.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $171.19 Million |
|---|---|
| Enterprise Value | $169.50 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.47 |
| Beta | 1.1 |
| Outstanding Shares | 27,305,028 |
Return
| Return on Equity | -31.10% |
|---|---|
| Return on Assets | -10.47% |
| Return on Invested Capital | -13.41% |
Valuation & Multiples
| P/E Ratio | -16.55 |
|---|---|
| PEG | 36.57 |
| Price to Sales | 3.35 |
| Price to Book Ratio | 6.7 |
| Enterprise Value to Revenue | 2.62 |
| Enterprise Value to EBIT | -23.54 |
| Enterprise Value to Net Income | -18 |
| Total Debt to Enterprise | 0.15 |
| Debt to Equity | 0.83 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 19, 2026
EPS Estimate
$-0.03
Average shareholder expectationRevenue Estimate
$20.42 M
Average shareholder expectationNext Earnings Call
Expected Date
August 11, 2026
EPS Estimate
$-0.01
Average shareholder expectationRevenue Estimate
$18.37 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | 27,700▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 48.39%▲ 4.22% |
|---|---|
| Total Invested | $55.72M▼ 34.43% |
| Investors Holding | 72▼ 4.00% |
ESG Score
No data